ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2026
Gamma knife radiosurgery in pediatric neuro-oncology: histology-specific outcomes and age-adapted procedural strategies.
Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeGamma Knife radiosurgery (GKRS) is increasingly applied in pediatric neuro-oncology; however, integrated analyses of outcomes and procedural factors remain limited. This study evaluated histology-specific outcomes and technical considerations of GKRS for pediatric brain tumors.
methodsThis study retrospectively analyzed 139 GKRS procedures performed in 108 pediatric patients (age 3-18 years) with brain tumors between 2002 and 2024. The clinical, radiological, dosimetric, and anesthetic data were analyzed. Progression-free survival (PFS) was estimated by Kaplan-Meier analysis and stratified by tumor histology.
resultsThe mean age at GKRS was 12.4 years (M: F ratio 1:1.16). The most common histologies were craniopharyngiomas (31 procedures), vestibular schwannomas (20), and pilocytic astrocytomas (16). The mean target coverage was 96.9% and the mean prescription dose was 18 Gy. Frameless mask fixation was feasible from age 6 and frame-based fixation from age 12. General anesthesia was required in 25.9%, predominantly in younger or uncooperative patients (8.5 vs 14.0 years, p < 0.001). Pediatric-type diffuse high-grade gliomas had the poorest outcomes (PFS 2.6 months, 100% mortality). Craniopharyngiomas showed high recurrence (48%) but a long failure interval (35.8 months) and low mortality (8%). Benign and low-grade tumors showed durable local control with a 5-year PFS exceeding 70%.
conclusionGKRS provides durable local control in selected benign and low-grade pediatric brain tumors; however, outcomes remain poor in aggressive histologies, with high rates of progression and mortality. These findings highlight the importance of histology-based patient selection and integration of GKRS into multimodal treatment strategies. Age-adapted procedural approaches facilitate safe application in pediatric patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.